2024 Q3 Form 10-Q Financial Statement

#000147793224004204 Filed on July 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $180.3K $284.2K
YoY Change 73.55% -59.18%
% of Gross Profit
Research & Development $445.6K $255.4K
YoY Change 258.91% 26.57%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $625.8K $539.6K
YoY Change 174.47% -39.91%
Operating Profit -$625.8K
YoY Change 174.47%
Interest Expense $204.5K -$98.81K
YoY Change 971.03% 4086.86%
% of Operating Profit
Other Income/Expense, Net $545.4K $0.00
YoY Change
Pretax Income -$80.44K -$7.556M
YoY Change -63.74% 674.74%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$80.44K -$7.556M
YoY Change -63.74% 674.74%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.11
COMMON SHARES
Basic Shares Outstanding 72.81M shares 80.26M shares 66.58M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.59K $23.25K
YoY Change 185.91% -88.31%
Cash & Equivalents $23.01K $26.59K $23.25K
Short-Term Investments
Other Short-Term Assets $35.91K $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses $2.465M
Receivables $240.0K $0.00
Other Receivables $45.30K $0.00
Total Short-Term Assets $2.999M $71.89K $23.25K
YoY Change 12800.42% -99.56% -99.92%
LONG-TERM ASSETS
Property, Plant & Equipment $19.56K $4.691M $4.818M
YoY Change -99.59% -2.65%
Goodwill
YoY Change
Intangibles $1.662M $0.00
YoY Change
Long-Term Investments $2.725M $2.725M
YoY Change -9.17%
Other Assets $20.72K
YoY Change
Total Long-Term Assets $9.033M $9.099M $7.543M
YoY Change 19.75% 16.38%
TOTAL ASSETS
Total Short-Term Assets $2.999M $71.89K $23.25K
Total Long-Term Assets $9.033M $9.099M $7.543M
Total Assets $12.03M $9.171M $7.567M
YoY Change 59.02% -62.25% -72.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $965.3K $787.4K $265.9K
YoY Change 263.01% 551.52% 438.9%
Accrued Expenses $341.4K $134.3K
YoY Change 161.37% 21217.46%
Deferred Revenue
YoY Change
Short-Term Debt $2.611M $213.0K
YoY Change 1761.98% 965.05%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.110M $1.908M $1.126M
YoY Change 531.57% 118.43% 151.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.562M $4.691M
YoY Change -2.74%
Total Long-Term Liabilities $4.562M $4.691M
YoY Change -2.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.110M $1.908M $1.126M
Total Long-Term Liabilities $4.562M $4.691M
Total Liabilities $11.67M $6.470M $5.817M
YoY Change 100.67% 16.28% 1200.24%
SHAREHOLDERS EQUITY
Retained Earnings -$56.14M -$53.45M -$52.66M
YoY Change 6.62% 50.99% 61.9%
Common Stock $72.81K $72.81K $67.64K
YoY Change 7.64% 9.36% 16.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $360.6K $2.701M $1.750M
YoY Change
Total Liabilities & Shareholders Equity $12.03M $9.171M $7.567M
YoY Change 59.02% -62.25% -72.4%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q3
OPERATING ACTIVITIES
Net Income -$80.44K -$7.556M
YoY Change -63.74% 674.74%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities $220.00 $25.94K
YoY Change -100.53% -102.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$20.72K
YoY Change
Cash From Investing Activities -$20.72K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 45.30K -11.99K
YoY Change -101.01%
NET CHANGE
Cash From Operating Activities 220.0 25.94K
Cash From Investing Activities -20.72K
Cash From Financing Activities 45.30K -11.99K
Net Change In Cash 24.80K 13.95K
YoY Change -159.92% -56.3%
FREE CASH FLOW
Cash From Operating Activities $220.00 $25.94K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4818471 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23250 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
71893 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1662199 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2023Q3 us-gaap Investments
Investments
2725000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4691011 usd
CY2024Q2 us-gaap Assets
Assets
9170826 usd
CY2024Q2 asre Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
443566 usd
CY2023Q3 asre Accounts Payable Related Party Current
AccountsPayableRelatedPartyCurrent
322500 usd
CY2024Q2 asre Refundable Deposits Current
RefundableDepositsCurrent
190000 usd
CY2023Q3 asre Refundable Deposits Current
RefundableDepositsCurrent
190000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
212849 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
6840 usd
CY2024Q2 asre Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
0 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
100000 usd
CY2024Q2 asre Debenture Payable Current
DebenturePayableCurrent
0 usd
CY2023Q3 asre Debenture Payable Current
DebenturePayableCurrent
20000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
128519 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
127460 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1907641 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1125728 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4562489 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4691011 usd
CY2024Q2 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
5000 usd
CY2023Q3 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
5000 usd
CY2024Q2 asre Common Stock To Be Issued
CommonStockToBeIssued
0 usd
CY2023Q3 asre Common Stock To Be Issued
CommonStockToBeIssued
0 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56078966 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54341562 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53447141 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52655280 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2700696 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1749982 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9170826 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7566721 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-9664 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
71512 usd
us-gaap Profit Loss
ProfitLoss
-2874057 usd
asre Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
0 usd
asre Stock Based Compensation Related Party
StockBasedCompensationRelatedParty
1506000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
34375 usd
us-gaap Share Based Compensation
ShareBasedCompensation
420900 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22801 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
20197 usd
asre Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
0 usd
asre Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
-36242 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
97900 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-93011 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-59984 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
209209 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21234 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-619102 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
100000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
65000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
264500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45300 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
429500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3343 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-189602 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23250 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
198899 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9297 usd
asre Common Stock Issued For Investment
CommonStockIssuedForInvestment
0 usd
asre Common Stock Issued For Investment
CommonStockIssuedForInvestment
3000000 usd
asre Common Stock Issued For License Asset
CommonStockIssuedForLicenseAsset
1685000 usd
asre Common Stock Issued For License Asset
CommonStockIssuedForLicenseAsset
0 usd
asre Common Stock Issued For Prepayment Of Acquisition
CommonStockIssuedForPrepaymentOfAcquisition
0 usd
asre Common Stock Issued For Prepayment Of Acquisition
CommonStockIssuedForPrepaymentOfAcquisition
6687912 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</p>
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22801 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
1259000 shares
CY2024Q2 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
1
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1259000 shares
us-gaap Net Income Loss
NetIncomeLoss
-791861 usd
us-gaap Net Income Loss
NetIncomeLoss
-2874057 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53447141 usd
asre Amount Of Project Related To Payment
AmountOfProjectRelatedToPayment
195000000 usd
CY2023Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.10 pure
CY2022Q1 us-gaap Convertible Debt
ConvertibleDebt
20000 usd
CY2022Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2022Q1 asre Debenture Converted Description
DebentureConvertedDescription
the right to convert any time within 2 years
CY2022Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1
asre Liquidation Description
LiquidationDescription
Liquidation Preference Amount which is the product of the stocks Stated Value of $40.00 per share plus 120% before any payment or distribution of assets to the holders of Common Stock or any other Junior Stock
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
125000 shares
CY2024Q2 us-gaap Share Price
SharePrice
0.275
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
34375 usd
CY2022Q3 asre Subscription Receivables Share
SubscriptionReceivablesShare
10000 shares
CY2022Q3 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
5000 usd
CY2024Q2 asre Warrant Outstanding
WarrantOutstanding
1259000 shares
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2326000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.00
CY2023 asre Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Start
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermStart
P1Y6M3D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
569000 shares
CY2023 asre Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term Granted
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted
P2Y
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1259000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.00
asre Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Start
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermStart
P0Y6M3D
dei Entity Central Index Key
EntityCentralIndexKey
0001231339
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72810382 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67638982 shares
asre Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual End Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualEndPeriod
P6M4D
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-05-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52205
dei Entity Registrant Name
EntityRegistrantName
Astra Energy, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3113571
dei Entity Address Address Line1
EntityAddressAddressLine1
1100 Benjamin Franklin Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 802
dei Entity Address City Or Town
EntityAddressCityOrTown
Sarasota
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34236
dei City Area Code
CityAreaCode
1-800
dei Local Phone Number
LocalPhoneNumber
705-2919
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
ASRE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
72810382 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26593 usd
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
45300 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
23250 usd
CY2024Q2 us-gaap Investments
Investments
2725000 usd
CY2024Q2 asre Automobile Net
AutomobileNet
20723 usd
CY2023Q3 asre Automobile Net
AutomobileNet
0 usd
CY2023Q3 us-gaap Assets
Assets
7566721 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
787407 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
265917 usd
CY2023Q3 asre Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
93011 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
100000 usd
CY2024Q2 asre Note Payable
NotePayable
2510500 usd
CY2023Q3 asre Note Payable
NotePayable
0 usd
CY2024Q2 asre Note Payable Contra Account
NotePayableContraAccount
-2465200 usd
CY2023Q3 asre Note Payable Contra Account
NotePayableContraAccount
0 usd
CY2024Q2 us-gaap Liabilities
Liabilities
6470130 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5816739 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72810382 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67638982 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
72810 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
67639 usd
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
96253 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36362 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
163965 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
117299 usd
CY2024Q2 us-gaap Business Development
BusinessDevelopment
445586 usd
CY2023Q2 us-gaap Business Development
BusinessDevelopment
124152 usd
us-gaap Business Development
BusinessDevelopment
641946 usd
us-gaap Business Development
BusinessDevelopment
564344 usd
CY2024Q2 asre Land Lease And Penalties Expense
LandLeaseAndPenaltiesExpense
0 usd
asre Land Lease And Penalties Expense
LandLeaseAndPenaltiesExpense
0 usd
asre Land Lease And Penalties Expense
LandLeaseAndPenaltiesExpense
217897 usd
CY2023Q2 asre Land Lease And Penalties Expense
LandLeaseAndPenaltiesExpense
0 usd
CY2024Q2 asre Consulting Related Party
ConsultingRelatedParty
0 usd
CY2023Q2 asre Consulting Related Party
ConsultingRelatedParty
2500 usd
asre Consulting Related Party
ConsultingRelatedParty
0 usd
asre Consulting Related Party
ConsultingRelatedParty
3460 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22801 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q2 us-gaap Officers Compensation
OfficersCompensation
84000 usd
CY2023Q2 us-gaap Officers Compensation
OfficersCompensation
57000 usd
us-gaap Officers Compensation
OfficersCompensation
243000 usd
us-gaap Officers Compensation
OfficersCompensation
1677000 usd
CY2024Q2 asre Stock Compensation Consulting
StockCompensationConsulting
0 usd
CY2023Q2 asre Stock Compensation Consulting
StockCompensationConsulting
8000 usd
asre Stock Compensation Consulting
StockCompensationConsulting
34375 usd
asre Stock Compensation Consulting
StockCompensationConsulting
443400 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
625839 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
228014 usd
us-gaap Operating Expenses
OperatingExpenses
1323984 usd
us-gaap Operating Expenses
OperatingExpenses
2805503 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-625839 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-228014 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1323984 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2805503 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-193 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
4684 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-8068 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
4319 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
204503 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
19094 usd
us-gaap Interest Expense
InterestExpense
209909 usd
us-gaap Interest Expense
InterestExpense
26967 usd
CY2024Q2 asre Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
0 usd
CY2023Q2 asre Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
0 usd
asre Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
0 usd
asre Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
-36242 usd
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
20597 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-9664 usd
CY2024Q2 us-gaap Other Income
OtherIncome
750100 usd
CY2023Q2 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
750100 usd
us-gaap Other Income
OtherIncome
0 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
545404 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6187 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
532123 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-68554 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-80435 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-221827 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-791861 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2874057 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-80435 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-221827 usd
us-gaap Net Income Loss
NetIncomeLoss
-791861 usd
us-gaap Net Income Loss
NetIncomeLoss
-2874057 usd
CY2024Q2 asre Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
-0.00
CY2023Q2 asre Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
-0.00
asre Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
-0.01
asre Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
-0.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72803321 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66141482 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72174089 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61536642 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1749982 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
34375 usd
CY2023Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1685000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-315791 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3153566 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-395635 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2757931 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
23200 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-80435 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2700696 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
26972060 usd
CY2022Q4 asre Shares Issued For Services Related Party Amount
SharesIssuedForServicesRelatedPartyAmount
848500 usd
CY2022Q4 asre Shares Issued For Services Amount
SharesIssuedForServicesAmount
347500 usd
CY2022Q4 asre Shares Issued For Acquisition Amount
SharesIssuedForAcquisitionAmount
8555000 usd
CY2022Q4 asre Common Stock Issued For Cash Amount
CommonStockIssuedForCashAmount
264500 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1603239 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
35384321 usd
CY2023Q1 asre Shares Issued For Services Related Party Amount
SharesIssuedForServicesRelatedPartyAmount
657500 usd
CY2023Q1 asre Shares Issued For Services Amount
SharesIssuedForServicesAmount
65400 usd
CY2023Q1 asre Shares Issued For Acquisition Amount
SharesIssuedForAcquisitionAmount
1132913 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1048991 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
36191143 usd
CY2023Q2 asre Shares Issued For Services Amount
SharesIssuedForServicesAmount
8000 usd
CY2023Q2 asre Shares Issued For Acquisition Amount
SharesIssuedForAcquisitionAmount
80000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-221827 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
36057316 usd
us-gaap Profit Loss
ProfitLoss
-791861 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
45300 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
521487 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
121066 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
0 usd
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
150000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2524 usd
asre Payments To Acquire Automobile
PaymentsToAcquireAutomobile
20723 usd
asre Payments To Acquire Automobile
PaymentsToAcquireAutomobile
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20723 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
asre Proceeds From Note Payable Related Party
ProceedsFromNotePayableRelatedParty
2510500 usd
asre Proceeds From Note Payable Related Party
ProceedsFromNotePayableRelatedParty
0 usd
asre Proceedsfromnote Payable Contra Account
ProceedsfromnotePayableContraAccount
-2465200 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26593 usd
asre Establish Right Of Use Asset
EstablishRightOfUseAsset
0 usd
asre Establish Right Of Use Asset
EstablishRightOfUseAsset
4818470 usd
asre Common Stock Issued For Conversion Of Debt
CommonStockIssuedForConversionOfDebt
23200 usd
asre Common Stock Issued For Conversion Of Debt
CommonStockIssuedForConversionOfDebt
0 usd
CY2023Q3 asre Remainingcash Received
RemainingcashReceived
750000 usd
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
4000000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
4000000 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-80435 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-221827 usd
CY2024Q2 asre Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
-0.00
CY2023Q2 asre Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
-0.00
asre Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
-0.01
asre Net Income Loss Per Share Basic And Diluted
NetIncomeLossPerShareBasicAndDiluted
-0.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72803321 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66141482 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72174089 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61536642 shares
us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
54000 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
54000 usd
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
46400 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
46400 shares
asre Principal Amount
PrincipalAmount
20000 usd
us-gaap Interest Paid
InterestPaid
3200 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.00
CY2023 asre Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Expired In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrExpiredInPeriodGross
0 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023 asre Number Of Warrant Exercised
NumberOfWarrantExercised
0 shares
CY2023 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2895000 shares
CY2023 asre Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual End Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualEndPeriod
P0Y6M21D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
asre Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Expired In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrExpiredInPeriodGross
-1636000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
asre Number Of Warrant Exercised
NumberOfWarrantExercised
0 shares
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0

Files In Submission

Name View Source Status
0001477932-24-004204-index-headers.html Edgar Link pending
0001477932-24-004204-index.html Edgar Link pending
0001477932-24-004204.txt Edgar Link pending
0001477932-24-004204-xbrl.zip Edgar Link pending
asre-20240531.xsd Edgar Link pending
asre-20240531_cal.xml Edgar Link unprocessable
asre_10q.htm Edgar Link pending
asre-20240531_def.xml Edgar Link unprocessable
asre-20240531_lab.xml Edgar Link unprocessable
asre-20240531_pre.xml Edgar Link unprocessable
asre_ex311.htm Edgar Link pending
asre_ex312.htm Edgar Link pending
asre_ex321.htm Edgar Link pending
asre_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
asre_10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending